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The chemotherapeutic agent cisplatin often causes severe
renal dysfunction; however, the molecular mechanism
causing renal injury remains unclear. In wild-type mice,
intrarenal interferon (IFN)-c gene expression was found to be
enhanced while CD3þ T cells and Ly-6G neutrophils were the
main cellular source of IFN-c following cisplatin injection.
Compared to wild-type mice, cisplatin-treated IFN-c-deficient
(IFN-c/) mice exhibited exaggerated histopathological
changes with higher blood urea nitrogen and creatinine
levels. Cisplatin-induced apoptosis was associated with
enhanced caspase-3 activation in renal proximal tubular
epithelial cells, with effects suppressed by IFN-c resulting in
increased cell viability. IFN-c significantly reduced the levels
of the autophagic markers LC3-II and p62, and enhanced
cathepsin D expression in cisplatin-treated renal proximal
tubule epithelial cells, implying that IFN-c can accelerate
autophagic flux. Tubular cell apoptosis was more evident
with enhanced caspase-3 activation in IFN-c-deficient
compared to wild-type mice. Elevated intrarenal LC3-II and
increased p62 accumulation were associated with reduced
cathepsin D activation in IFN-c-deficient mice, implying that
the absence of IFN-c suppressed autophagic flux. Thus, IFN-c
can accelerate autophagic flux by augmenting cathepsin D
levels and reciprocally increasing the viability of renal tubular
cells, thereby attenuating cisplatin-induced acute renal
injury.
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Cisplatin is a widely used chemotherapeutic agent for the
treatment of a variety of malignancies, including head and
neck, ovarian, and testicular cancers. However, approximately
25–30% of patients develop renal dysfunction after receiving
a single dose of cisplatin.1–3 Renal dysfunction can often be
severe and precludes the administration of clinically effective
doses of cisplatin.2 Several molecular mechanisms are
proposed as the pathogenesis of cisplatin-induced nephro-
toxicity, such as the generation of reactive oxygen species,3
caspase activation,4 DNA damage,5,6 and mitochondrial
damage.7 Moreover, intrarenal inflammation is reported to
augment cisplatin-induced renal injury by producing proin-
flammatory cytokines including tumor necrosis factor-a,
interleukin-1b, and interleukin-6.8–11
Cisplatin-induced renal injury is pathologically character-
ized by tubular epithelial cell death.12 Cisplatin induces
both apoptosis and necrosis in the renal tubular epithelial
cells.13,14 The type of cell death in tubular epithelial cells
seems to depend on the dose of cisplatin; apoptosis is the
main cell death at a lower dose of cisplatin, whereas almost all
cell death is necrosis at higher doses.15–17 Recently, several
groups proposed that autophagy may be involved in the
pathogenesis of cisplatin-induced renal injury.18,19 Auto-
phagy is a dynamic and multistep process. In the initial step
of this process, parts of the cytoplasm and cellular organelles
are engulfed in a double-membrane vesicle called the
‘autophagosome’. An autophagosome eventually fuses
with lysosomes, resulting in degradation of the sequestered
materials by various lysosomal enzymes. Autophagic flux
refers to the complete process of these whole steps.20
Autophagosome formation can convert LC3-I to LC3-II,
whereas autophagic flux–mediated lysosomal enzyme activa-
tion can degrade LC3-II. Moreover, p62 protein serves
as a link between LC3-II and ubiquitinated substrates
and is incorporated into autolysosomes, where it is degraded.
Thus, the amount of p62 is inversely correlated with
autophagic flux.
Autophagy takes part in cell survival or death in a context-
dependent manner, and has been implicated in development,
aging, neurodegeneration, and cancer. Moreover, recent
studies have shown that the cross talk between apoptosis
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and autophagy can determine the fate of tubular epithelial
cells in cisplatin-induced renal injury.18,19
Interferon (IFN)-g exerts pleiotropic effects on NK cells
and macrophages, including enhancement of their antiviral
and bactericidal activities and upregulation of major
histocompatibility complex class II expression on macro-
phages.21 Many reports have suggested that IFN-g is a major
mediator in various types of disease models.22–27 Moreover,
IFN-g has proapoptotic effects as many cytokines do.28–31
Simultaneously, IFN-g stimulates autophagy in some patho-
gen-infected cells, thereby inducing the presentation of
pathogen-derived antigens.32,33
However, the pathophysiological roles of IFN-g in cisplatin-
induced renal injury remain unclear, particularly with respect
to the effects of IFN-g on apoptosis and autophagy. Hence, we
explored the roles of IFN-g in the pathogenesis of cisplatin-
induced renal injury in IFN-g-deficient mice (IFN-g/ mice).
Here, we provide definitive evidence to indicate that bone
marrow (BM)–derived cells produce IFN-g intrarenally, which
reduces the rate of apoptosis by enhancing autophagic flux in
the renal tubular cells and ultimately attenuates cisplatin-
induced acute renal injury.
RESULTS
Enhanced intrarenal IFN-c expression in WT mice after
cisplatin challenge
First, we examined intrarenal IFN-g expression at the gene and
protein levels in wild-type (WT) mice after cisplatin challenge.
Intrarenal IFN-g mRNA expression was transiently increased at
6 h after cisplatin challenge (Po0.05), declining gradually
below basal level at 5 days (Figure 1a and b). Immunohisto-
chemical analysis detected IFN-g protein in infiltrating
leukocytes but not in renal parenchymal cells (data not shown).
To identify IFN-g-expressing cells, flow cytometric analysis was
conducted on the single-cell population prepared from
cisplatin-treated kidney and revealed that major cellular sources
of IFN-g were CD3þ T cells at 6 h (Figure 1c) and Ly-6Gþ
neutrophils at 1 day after cisplatin treatment (Figure 1d). These
observations suggested the involvement of endogenous IFN-g
in the pathogenesis of cisplatin-induced renal injury.
Exaggerated cisplatin-induced renal injury in IFN-c/ mice
There were no significant differences in renal morphology
and biochemical markers such as blood urea nitrogen (BUN)
and creatinine (CRE) levels between untreated WT and IFN-
g/ mice. Cisplatin administration increased serum BUN
and CRE levels to a greater extent in IFN-g/ mice
compared with WT (Po0.05) (Figure 2a and b). WT mice
exhibited histopathological alterations such as tubular
dilatation, cast formation, and epithelial desquamation with
interstitial hemorrhages (Figure 2c), as well as disappearance
of periodic acid–Schiff-positive brush borders in damaged
tubules (Figure 2d). These pathological changes were
augmented in IFN-g/ mice (Po0.05) (Figure 2c–e).
Similarly, the immunoneutralization of IFN-g exaggerated
cisplatin-induced renal injury (Po0.05) (Supplementary
Figure S1 online). Furthermore, to clarify the roles of BM-
derived cells in cisplatin-induced renal injury, we generated
BM chimeric WT and IFN-g/ mice. Irrespective of the
genotype of the recipients, cisplatin-induced renal injury was
significantly augmented in mice transplanted with BM cells
obtained from IFN-g/ mice compared with those from WT
mice, as evidenced by serum BUN and CRE levels (Po0.05)
(Figure 2f and Supplementary Figure S2 online). These
observations implied that IFN-g deficiency in BM-derived
cells could augment cisplatin-induced renal injury.
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Figure 1 |Analysis on interferon (IFN)-c expression in the kidney of wild-type (WT) mice. (a) Intrarenal gene expression for IFN-g was
analyzed by reverse transcriptase (RT)–PCR at the indicated time intervals after cisplatin challenge as described in Materials and Methods
section. Representative results from six independent experiments are shown here. (b) The ratios of IFN-g to b-actin were densitometrically
determined. All values represent means±s.e.m (n¼ 6 animals). **Po0.01, cisplatin-treated WT mice versus control mice. (c, d) WT mice
were killed at 6 h (c) or 48 h (d) after cisplatin challenge, and intracellular flow cytometry was performed on kidney-derived single-cell
suspensions to analyze intrarenal IFN-g-expressing cells. IFN-g-expressing cells were determined among CD3þ lymphocytes (c) or Ly-6Gþ
neutrophils (d) among CD45þ leukocytes. Representative results from four independent experiments are shown here.
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Effects of IFN-c on cisplatin-induced apoptosis in renal
proximal tubular epithelial cells (RPTECs)
Several lines of evidence indicated that tubular cell apoptosis
is responsible for cisplatin-induced renal injury.18,19,34–37
Hence, we next examined the effects of IFN-g on RPTECs
obtained from WT mice. As cisplatin failed to enhance
IFN-g expression in RPTECs (data not shown), the effects of
IFN-g on cisplatin-induced damage in RPTECs was
assessed by adding recombinant IFN-g (10 U/ml) to the
culture medium. In line with in vivo observations, the
addition of IFN-g significantly increased cell viability in
cisplatin-treated RPTECs (Po0.05), indicating that IFN-g
had a protective role against cisplatin-induced cytotoxicity
(Figure 3a). In contrast, the addition of IFN-g had no effects
on RPTECs in the absence of cisplatin (data not shown).
Moreover, cisplatin increased the number of terminal
deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL)-positive RPTECs and was associated with the
activation of caspase-3, a hallmark of apoptosis,37,38 whereas
IFN-g significantly reduced these effects (Po0.05) (Figures
3b, c, 4a, and b).
Effects of IFN-c on cisplatin-induced autophagy in RPTECs
Evidence suggests that autophagy can protect renal
tubular cells from cisplatin-induced apoptosis.18,19 In line
with this, the inhibition of autophagic flux by lysosome
inhibitors (E64d and pepstatin) or bafilomycin A1 (a
vacuolar type H (þ )-ATPase inhibitor) further reduced the
cell viability of cisplatin-treated RPTECs (Po0.05) (Figure
3a), whereas these inhibitors did not affect RPTEC viability
in the absence of cisplatin (not shown). Hence, we next
examined the effects of IFN-g on cisplatin-induced autopha-
gic process in RPTECs. As the amount of LC3-II is closely
correlated with the number of autophagosomes,39 we
determined the amount of LC3-II as a marker of autophago-
some formation. Cisplatin increased the level of LC3-II,
progressively later than 6 h, but IFN-g attenuated cisplatin-
induced increase in LC3-II at 12 h (Po0.05) (Figure 4a and c).
Consistently, IFN-g reduced LC3 puncta formation in
cisplatin-treated RPTECs (Figure 3d). A decrease in LC3-II
level can arise from the downregulation of autophagosome
formation or enhanced autophagic pathway by accelerated
protein degradation.40 To discriminate these possibilities, we
next examined the expression of activated cathepsin D, a
marker of lysosomal activation for autophagosome degrada-
tion, and p62, an indicator of autophagy suppression.41
IFN-g augmented cathepsin D expression but depressed p62
amounts in cisplatin-treated RPTECs (Po0.05) (Figure 4a, d,
and e), indicating that IFN-g enhanced autophagosome
degradation, and eventually autophagic flux. Several
lines of evidence imply that lysosomal acidification can
activate cathepsin D, and that IFN-g can reduce lysosomal
pH and eventually activate cathepsin D.42–44 Consistently,
IFN-g lowered lysosomal pH in cisplatin-treated RPTECs
(Figure 4f). Supportingly, bafilomycin A1 augmented
caspase 3 activation and accumulation of LC3-II and
p62 through reduction of autophagic flux in cisplatin-
treated RPTECs (Po0.05) (Figure 4a–e). Thus, these
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Figure 2 |Analysis of cisplatin-induced renal injury in mice.
Determination of serum blood urea nitrogen (BUN) (a) and serum
creatinine (CRE) (b) in wild type (WT) (open symbols) and
interferon-g-deficient (IFN-g–/–) mice (closed symbols) at the
indicated time intervals after cisplatin challenge. All values
represent means±s.e.m. (n¼ 15). *Po0.05, WT versus IFN-g–/–
mice. (c, d) Histopathological examinations on the kidneys from
WT and IFN-g–/– mice at 5 days after cisplatin challenge.
Representative results from six individual animals are shown here.
(e) The histopathological score of the kidneys was determined as
described in Materials and Methods section. All values represent
mean±s.e.m. (n¼ 15). **Po0.01, WT versus IFN-g–/– mice. (f) The
effects of bone marrow (BM) transplantation on cisplatin-induced
renal injury. Recipient mice were transplanted with BM cells from
IFN-g–/– or WT donors as described in Materials and Methods
section. BM chimeric mice were injected with cisplatin at 60 days
after BM transplantation. Serum BUN in chimeric mice was
determined at the indicated time intervals after cisplatin
challenge. Each value represents mean±s.e.m. (n¼ 16). *Po0.05,
WT donor versus IFN-g–/– donor mice. KO, knockout.
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observations implied that IFN-g could activate cathepsin
D by lowering lysosomal pH, and eventually accelerate
autophagic flux.
IFN-c/ mice exhibited enhanced cisplatin-induced
apoptosis of renal tubular cells with a reciprocal suppression
of autophagic flux
We examined the molecular mechanisms underlying ex-
aggerated cisplatin-induced nephrotoxicity in IFN-g/
mice. TUNEL-positive nuclei of renal tubular cells were
more evident in IFN-g/ mice than in WT mice at 3 days
after treatment (Figure 5a and b). Although cisplatin
treatment activated caspase-3 in the kidneys of both strains,
the levels of activated caspase-3 were significantly higher in
IFN-g/ mice than in WT mice at 1 and 3 days after
cisplatin challenge (Po0.05) (Figure 6a and b). Cisplatin
treatment increased intrarenal levels of LC3-II to a similar
extent in WT and IFN-g/ mice at 6 h (P40.05). LC3-II
returned to basal levels in WT mice at 1 day, whereas it
remained elevated at 1 and 3 days in IFN-g/ mice
(Po0.05) (Figure 6a and c). However, cisplatin-induced
Atg12-Atg5 complex formation was increased, to a similar
extent, in both mouse strains, implying that there was no
significant difference in autophagy induction between WT
and IFN-g/ mice (P40.05) (Figure 6a and d). Intrarenal
cathepsin D level was lower in IFN-g/ mice compared
with WT (Po0.05) (Figure 6a and e), whereas the intrarenal
amount of p62 was significantly elevated later than 6 h in
IFN-g/ mice compared with WT mice (Po0.05) (Figure
6a and f). In contrast, at 5 days after cisplatin treatment,
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Figure 3 | Effects of interferon (IFN)-c and lysosomal inhibitors on cisplatin cytotoxicity for renal proximal tubular epithelial cells
(RPTECs). (a) The cell viability of RPTECs was assessed at 12 h after the treatment with cisplatin (50 mmol/l), cisplatin and IFN-g (10 U/ml),
cisplatin and lysosome inhibitors, or cisplatin and bafilomycin. All values represent means±s.e.m. (n¼ 12 experiments). *Po0.05; **Po0.01,
versus cisplatin alone. (b–d) Immunofluorescence analyses of RPTECs at 12 h after cisplatin challenge (50 mmol/l) with or without IFN-g (10 U/
ml). (b) Cleaved caspase-3 (red) with 4,6-diamidino-2-phenylindole (DAPI); (c) terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) staining (green) with DAPI; (d) LC3 (red) with DAPI. Representative results from six independent experiments are shown here
(original magnification,  600).
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there were no significant differences in the expression of
LC3-II, Atg12-Atg5, cathepsin D, and p62 between WT and
IFN-g/ mice (data not shown). Electron microscopic
observations revealed that autophagosomes accumulated in
tubular cells to a greater extent in IFN-g/ mice than in WT
at 3 days after cisplatin treatment (Figure 7a–c). Moreover,
the administration of exogenous IFN-g to IFN-g/ mice
reduced intrarenal levels of LC3-II and p62 at 3 days after
cisplatin challenge (Supplementary Figure S3 online). Thus,
these observations would indicate that IFN-g promoted
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Figure 4 |Western blotting analysis of cleaved caspase-3, LC3, cathepsin D, and p62 in renal proximal tubular epithelial cells
(RPTECs) treated with cisplatin, cisplatin and IFN-c, or cisplatin and bafilomycin (baf). (a) Representative results from six independent
experiments are shown here. (b–e) The ratios of each molecule to b-actin were densitometrically determined: (b), cleaved caspase-3;
(c), LC3-II; (d), cathepsin D; (e), p62. All values represent means±s.e.m. (n¼ 6). *Po0.05; **Po0.01, cisplatin alone versus cisplatin with
interferon (IFN)-g. (f) Effects of IFN-g on vacuolar pH in RPTECs treated with cisplatin were examined with LysoSensor. Representative results
from six independent experiments are shown here.
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Figure 5 |Analyses of intrarenal apoptosis in mice administered cisplatin. (a) Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) analysis was conducted on the kidneys from mice at 3 days after cisplatin challenge, as described in Materials and Methods
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autophagic flux in the kidney, and that enhanced cisplatin-
induced renal injury in IFN-g/ mice may be due to
impaired autophagic flux, which persisted up to 3 days after
cisplatin treatment.
IFN-c affected cisplatin-induced intrarenal accumulation of
polyubiquitinated peptides in vivo and in vitro
Autophagy and the ubiquitin–proteasome system function-
ally cooperate to degrade cytoplasmic proteins and thereby
recycle amino acids.45 Hence, we next examined the effects of
IFN-g on the accumulation of polyubiquitinated peptides in
RPTECs and kidneys after cisplatin treatment. IFN-g reduced
cisplatin-induced polyubiquitinated peptide accumulation,
and lysosomal protease inhibitors (suppression of autophagic
flux) canceled its effects in RPTECs (Figure 8a). Consistently,
cisplatin treatment increased the numbers of ubiquitin-
positive cells to a larger extent in IFN-g/ mice compared
with WT (Figure 8b). Thus, IFN-g can also reduce the
accumulation of polyubiquitinated peptides by accelerating
autophagic flux.
The administration of IFN-c attenuated cisplatin-induced
renal injury in WT mice
We finally examined the effects of exogenous IFN-g on
cisplatin-induced renal injury. When WT mice received a
single subcutaneous injection of IFN-g (500–10,000 U per
mouse) immediately after cisplatin challenge, we failed to find
therapeutic effects of IFN-g on cisplatin-induced renal injury
(data not shown). In contrast, the continuous infusion of a
small dose of IFN-g (15 U/day per mouse) into WT mice
significantly reduced cisplatin-induced elevation of serum BUN
and CRE levels, compared with vehicle treatment (Po0.05)
(Figure 9). These observations implied that IFN-g can be
effective for the prevention of cisplatin-induced renal injury.
DISCUSSION
IFN-g is a pleiotropic cytokine that is involved in various
pathological conditions including kidney diseases.22–27 Our
observations suggest that IFN-g has a protective role in
cisplatin-induced nephrotoxicity. By contrast, Tadagavadi
and Reeves46 demonstrated that immunoneutralization of
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IFN-g had no effects on renal dysfunction in C57BL/6 mice
administered with cisplatin of 20 mg/kg, implying that IFN-
g-independent mechanism(s) underlie tissue injury in
cisplatin-induced nephrotoxicity. However, these discrepan-
cies could be explained by differences in cisplatin doses and/
or the genetic background of mice.
In our previous study, sodium arsenite caused severe renal
injuries that were associated with enhanced IFN-g expression in
renal tubular cells.23 In renal tubular cells, an absence of IFN-g
attenuated the expression of MRP-1 (an ATP-binding cassette
transporter for arsenic excretion) and impaired arsenic
excretion from the kidney. This implies that IFN-g has a
protective role in sodium arsenite–induced renal injury through
the acceleration of arsenic excretion.23 Although this study also
demonstrated the protective role of IFN-g produced in
cisplatin-induced renal injury, there was no difference in the
expression of any ATP-binding cassette transporters (including
MRP-1) in renal tissue between cisplatin-treated WT and IFN-
g/ mice (data not shown). These observations suggest that
IFN-g might have protective roles in cisplatin-induced renal
injury through different mechanisms, in comparison with
sodium arsenite–induced renal injury.
In cisplatin-induced renal injury, T-cell recruitment
peaked at 12 h, declined by 24 h, and T-cell–mediated
neutrophil infiltration ensued thereafter.10 We observed that
cisplatin challenge induced IFN-g expression in CD3þ T cells
at an early time point, 6 h after cisplatin treatment, and in Ly-
6Gþ neutrophils at the later phase. On the contrary, cisplatin
treatment failed to enhance IFN-g expression in renal
parenchymal cells. Given the fact that the gene expression
of IFN-g peaked at 6 h after cisplatin challenge, T-cell–derived
IFN-g at early phase might be more crucial for protection
against cisplatin-induced nephrotoxicity.
Cisplatin causes apoptosis mainly in proximal tubular
epithelial cells of the kidneys, eventually resulting in severe
renal dysfunction.12–17 Various mechanisms are proposed to
underlie cisplatin-induced death, including a caspase 9–
dependent mitochondrial pathway, Fas- and tumor necrosis
factor receptor 1–mediated pathway, and an endoplasmic
reticulum stress–induced pathway.34–37 IFN-g, a pleiotropic
and multifunctional cytokine, can act as a proapoptotic
factor in all these apoptotic pathways.47–51 Our hypothesis
that cisplatin-induced renal dysfunction would be depressed
in IFN-g/ mice was based on the observations that IFN-g
expression is increased in kidneys treated with cisplatin. In
contrast to our assumption, exaggerated renal injury together
with enhanced tubular epithelial cell apoptosis was observed
after cisplatin treatment in IFN-g/ mice compared with
WT mice. Thus, these observations suggest that IFN-g acts as
a protective mediator in cisplatin-induced renal injury.
Autophagy is well conserved from yeast to mammals and
is an indispensable cytoprotective system, particularly against
starvation. Under starvation, autophagy acts as a catabolic
system in order to produce nutrients by recycling cellular
components.20 ‘Autophagic flux’ refers to the dynamic
process of autophagosome formation, engulfment, and
lysosomal fusion.20 Moreover, recent studies demonstrate
that autophagy is crucially involved in various biological
phenomena such as cell growth, development, homeostasis,
and cell death.52–55 Furthermore, in the process of cell death,
autophagy communicates with apoptosis in the following
different ways in a context-dependent manner: (1) autophagy
can act as a partner of apoptosis to induce cell death in a
coordinated or cooperative manner; (2) autophagy acts as an
antagonist to block apoptotic cell death by promoting cell
survival; and (3) autophagy acts as an executor of apoptosis,
participating in certain morphologic and cellular events that
occur during apoptotic cell death, without leading to death
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(a) Effects of interferon (IFN)-g and lysosomal protease inhibitors
on polyubiquitinated peptide accumulation in renal proximal
tubular epithelial cells (RPTECs). Polyubiquitinated peptides in
RPTECs were analyzed by western blotting after the cells were
cultured for 10 h with cisplatin in the presence or absence of
IFN-g or pepstatin A and E64d. Representative results from
six independent experiments are shown here. (b)
Immunohistochemical detection of polyubiquitinated peptides
in the kidney from wild-type (WT) and interferon-g-deficient
(IFN-g/) mice at 3 days after cisplatin challenge. Representative
results from six individual animals are shown here (original
magnification,  400).
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Figure 9 | Effects of interferon (IFN)-c infusion on cisplatin-
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were challenged with cisplatin (15 mg/kg) as described in
Materials and Methods section. Serum blood urea nitrogen (BUN)
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by itself.56,57 Similarly, there is a cross talk between autophagy
and apoptosis in cisplatin-induced renal injury in vitro and
in vivo,18,19 and the inhibition of autophagy enhanced
tubular cell apoptosis in cisplatin-induced renal injury in
either early or late stages of the autophagy pathway.18 Thus,
autophagy can attenuate cisplatin-induced renal injury
through antagonizing apoptotic cell death.
IFN-g enhances autophagy in macrophages infected
with Mycobacterium tuberculosis, and eventually caused
mycobacterial phagosomes to mature into phagolysosomes,
implying that IFN-g is required for antimycobacterial action
in innate immune system in macrophages.32 Moreover, IFN-
g-induced autophagy is involved in antigen processing using
major histocompatibility complex II.58 Thus, IFN-g-induced
autophagy is crucial to the immune system. However, it
remains elusive on the roles of IFN-g-induced autophagy
besides immune reactions. Here, we revealed that the absence
of IFN-g impaired autophagic flux as evidenced by the
elevated levels of intrarenal LC3-II and p62, and eventually
enhanced cisplatin-induced nephrotoxicity. Supportingly, in
in vitro analysis, the addition of IFN-g and cisplatin reduced
the levels of p62 and LC3-II, as compared with cisplatin
treatment alone. These observations strongly implied that
IFN-g could enhance autophagic flux.
Cathepsin D is an effector enzyme of autophagosome
degradation in the lysosomes, eventually resulting in the
acceleration of autophagic flux. IFN-g can directly augment
cathepsin D expression in keratinocytes,42 mammary epithe-
lial cells,43 and Hela cells.44 Moreover, IFN-g can lower
lysosomal pH and eventually induce proteolytic activation of
cathepsin D.43 We failed to detect a difference in intrarenal
gene expression of cathepsin D between WT and IFN-g/
mice even after cisplatin challenge (data not shown).
Consistently, IFN-g failed to enhance cathepsin D gene
expression (data not shown) but lowered intracellular pH in
RPTECs. Thus, IFN-g can accelerate autophagic flux through
pH-dependent cathepsin D activation in renal tubular cells
and can eventually attenuate cisplatin-induced apoptotic cell
death (Figure 10). This may account for our observation that
IFN-g deficiency enhanced cisplatin-induced apoptosis, in
contrast to the widely held view that IFN-g is proapoptotic in
many pathophysiological situations.
Several independent groups have proposed a collaboration
between the ubiquitin–proteasome system and autophagy in
protein quality control.45,56–61 When the ubiquitin–protea-
some system is insufficient for clearance of aggregated
proteins, autophagy can compensate for protein degradation.
Thus, the suppression of autophagic flux can excessively
increase the burden on the ubiquitin–proteasome system,
eventually leading to enhanced apoptosis.60,61 In line with
this, the acceleration of autophagic flux by IFN-g attenuated
polyubiquitinated peptide accumulation in cisplatin-treated
RPTECs. Consistently, the amounts of polyubiquitinated
proteins were increased in renal proximal tubular cells of
IFN-g/ mice with impaired autophagic flux. These
observations imply that IFN-g-mediated autophagy enhance-
ment can also reduce polyubiquitinated peptide accumula-
tion, thereby protecting tubular cells from cisplatin-induced
renal injury (Figure 10).
Taken together, the balance between proautophagic and
proapoptotic roles of IFN-g may depend on disease models.
In cisplatin-induced renal injury, proautophagic roles of IFN-
g can predominate over its proapoptotic roles. From the
clinical perspective, several lines of evidence indicate that
IFN-g prolonged progression-free survival when it was given
together with platinum derivatives to ovarian cancer
patients.62 Given that IFN-g can prevent nephrotoxicity,
which is a dose-limiting adverse effect of platinum derivatives
including cisplatin, we suggest that discontinuation of
platinum derivatives could be avoided by adjuvant IFN-g
treatment. This may enhance the efficacy of platinum
derivatives in treatment of ovarian cancer patients.
Cisplatin challenge
IFN-γ (+)
IFN-γ (-)
Lysosome
Autolysosome formation
Aggregate removal
Cytoprotection
ApoptosisLysosome
Attenuated cathepsin D expression
Ubiquitin Protein Mitochondria LC3-ll p62
Aggregate accumulation
Cathepsin D
Autophagosome formation
Damaged mitochondria
and proteins with
polyubiquitination
Figure 10 |Presumed mechanism showing how interferon (IFN)-c can accelerate autophagic protein degradation through the
activation of cathepsin D, and eventually prevent cisplatin-induced renal injury.
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MATERIALS AND METHODS
Reagents and antibodies (Abs)
Cisplatin, recombinant mouse IFN-g, Bafilomycin A1, and lysoso-
mal protease inhibitors (E64d and pepstatin A) were purchased
from Sigma-Aldrich (Tokyo, Japan), PeproTech (Rocky Hill, NJ),
and Calbiochem (San Diego, CA), respectively. The following
monoclonal Abs or polyclonal Abs (pAbs) were used for
immunohistochemical or western blotting analysis: rabbit anti-
LC3b pAbs (Sigma-Aldrich), rabbit anti-cleaved caspase-3 pAbs
(Cell Signaling Technology, Danvers, MA), goat anti-cathepsin D
pAbs (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-CD3
pAbs, and rabbit anti-p62/A170/SQSTM1 (p62) pAbs (Wako pure
Chemical Industries, Osaka, Japan).
Animals and cisplatin-induced renal injury
Pathogen-free 8- to 10-week-old male BALB/c mice were obtained
from Sankyo Laboratories (Tokyo, Japan) and designated as WT
mice in this study. Age- and sex-matched IFN-g–/– mice, backcrossed
to BALB/c mice for at least eight generations, were used in the
following experiments.22–27 All mice were housed individually in
cages under the specific pathogen-free conditions during the
experiments. For the induction of cisplatin-induced renal injury,
mice were given a single intraperitoneal injection of cisplatin
(15 mg/kg). At the indicated time intervals (0, 6 h, 1, and 3 days)
after cisplatin challenge, kidney samples were obtained and
subjected to the following experiments. In another series of
experiments, mice were subcutaneously injected with anti-IFN-g
Abs (100 mg per mouse) immediately before cisplatin administration
(PeproTech). All animal experiments were approved by the
Committee on Animal Care and Use in Wakayama Medical
University.
Flow cytometry
After being perfused with 20 ml of ice-cold phosphate-buffered
saline (PBS) to eliminate intravascular leukocytes, the kidneys were
removed, minced into fragments of 1 mm3, and digested with 1 mg/ml
collagenase type 4 (Worthington Biochemical, Lakewood, NJ)
and 100 U/ml DNase I (Worthington Biochemical) in Dulbecco’s
modified Eagle’s medium for 45 min at 37 1C. The digested tissues
were then passed sequentially through a 100-mm and then a 40-mm
mesh. The cell suspension was centrifuged, and red blood cells
in the resulting pellet were lysed using red blood cell lysis buffer
(Imgenex, San Diego, CA). The obtained single-cell preparations
were incubated with 25 mg/ml of Fc block (BD Biosciences
Pharmingen, Piscataway, NJ) for 15 min at 4 1C. The cells
were stained with fluorescein isothiocyanate-labeled anti-mouse
Ly-6G (eBioscience, San Diego, CA) or fluorescein isothiocyanate-
labeled anti-mouse CD3e (eBioscience) and PerCP-labeled
anti-mouse CD45 (BD Biosciences Pharmingen). The cells were
permeabilized using cytofix/cytoperm (BD Biosciences Pharmingen)
and stained with phycoerythrin-labeled anti-mouse IFN-g
(eBioscience). Control staining was performed using isotype-
matched monoclonal Abs. The stained cells were analyzed on
an Accuri C6 flow cytometer (BD Accuri Cytometers, Ann Arbor,
MI), and the obtained data were analyzed using the CFlow Software
(BD Accuri Cytometers).
Generation of BM chimeric mice
BM chimeric mice were prepared as described previously.63 BM
cells were collected from the femurs of donor mice by aspiration
and flushing. Recipient mice were irradiated to 15 Gy using an
RX-650 irradiator (Faxitron X-ray, Wheeling, IL). Further, the
animals intravenously received 5 106 BM cells from donor mice in
a volume of 200 ml of sterile PBS under anesthesia. Thereafter,
the mice were housed in sterilized microisolator cages and were
fed normal chow and autoclaved hyperchlorinated water for
60 days. Successful engraftment and reconstruction of the
BM in the transplanted mice were confirmed by PCR analysis for
WT or mutant IFN-g gene of peripheral blood of each chimeric
mouse 30 days after BM transplantation. After durable BM
engraftment was confirmed, mice were treated with cisplatin as
described above.
Determination of BUN and CRE in the serum
At the indicated time intervals (1–5 days) after cisplatin injection,
sera were collected to determine BUN and CRE levels with a Fuji
DRI-CHEM 5500 V (Fuji Medical System, Tokyo, Japan), according
to the manufacturer’s instructions.
Isolation of RPTECs
RPTECs were obtained from the cortex of BALB/c WT mice kidney
(male, 21–30 days old) as described previously.64 Freshly isolated
RPTECs were cultured in renal epithelial growth media (REGM
Bulletkit, Lonza Walkersville, Walkersville, MD) for 48 h, washed,
and cultured in the same media for 4–5 days before being treated
with cisplatin and other reagents. Purity of the obtained RPTECs
(490%) was determined by indirect immunofluorescence staining
with anti-E-cadherin and anti-smooth muscle actin for epithelial and
mesenchymal markers, respectively. Further, the cells were incubated
for 6, 12, or 24 h in the presence of various combinations of cisplatin
(50 mmol/l), recombinant mouse IFN-g (10 U/ml), bafilomycin
(100 nm/ml), E64d (10mg/ml), and pepstatin A (10mg/ml). Cell
viability was assessed with a Cell Counting Kit-8 (Dojin Laboratories,
Kumamoto, Japan), which was based on a formazan formation from
water-soluble tetrazolium salt (WST-8) in living cells.
Administration of mouse IFN-c
Continuous subcutaneous infusion of mouse IFN-g was performed
as described previously.65 Briefly, under deep anesthesia with
pentobarbital (50 mg/kg body weight), WT mice were implanted
with the Alzet micro-osmotic pump (Model 1007D, Muromachi
Kikai, Tokyo, Japan) into the dorsal subcutaneous cavity. The pump
delivered recombinant mouse IFN-g at a rate of 15 U/day per mouse
or PBS in the same volume into the subcutaneous cavity for 7 days.
The mice were administered with cisplatin at 2 days after the start of
subcutaneous infusion.
Semiquantitative reverse transcriptase–PCR
A semiquantitative reverse transcriptase–PCR was conducted as
described previously.63 Total RNAs were extracted from renal
samples using ISOGENE (Nippon Gene, Toyama, Japan). Five mg
of total RNA was reverse-transcribed at 42 1C for 1 h in a 20-ml
reaction mixture containing mouse Moloney leukemia virus reverse
transcriptase (Toyobo, Osaka, Japan) with oligo (dT) primers
(Amersham-Pharmacia Biotech Japan, Tokyo, Japan). Thereafter,
complementary DNA was amplified together with Taq polymerase
(Nippon Gene) using the specific sets of primers with the optimal
number of cycles at 94 1C for 1 min, optimal annealing temperature
for 1 min, and 72 1C for 1 min, followed by incubation at 72 1C for
3 min (Table 1). The PCR products were fractionated on a 2%
agarose gel and visualized by ethidium bromide staining. The band
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intensity of ethidium bromide fluorescence was measured using the
ImageJ Analysis Software Ver. 1.38x (National Institutes of Health,
Bethesda, MD), and the ratios of IFN-g to b-actin were determined.
Histopathological analyses
Kidney tissues were obtained at the indicated time intervals after
cisplatin challenge and were fixed in 4% formaldehyde buffered with
PBS (pH7.2), to prepare paraffin-embedded sections (6mm thick).
Thereafter, the sections were subjected to hematoxylin and eosin or
periodic acid–Schiff staining. The degree of renal damage was scored
with the examination of hemorrhages, the disappearance of periodic
acid–Schiff-positive brush border, and cast formation in 10
randomly chosen regions in each sample at a magnification of
 100. Renal morphological alterations were graded on a scale of
0–3þ as described previously: 0, normal; 1þ , slight; 2þ , moderate;
and 3þ , severe.63 The mean of all of the fields was taken as the
damage score in each sample. All measurements were recorded
without a prior knowledge of the experimental procedures.
Immunohistochemical analyses
Deparaffinized sections were immersed in 0.3% H2O2 in methanol for
30 min to eliminate endogenous peroxidase activities. The sections
were further incubated with PBS containing 1% normal serum
corresponding to the secondary Abs and 1% bovine serum albumin to
reduce nonspecific reactions. The sections were incubated with anti-
ubiquitin Abs at a concentration of 1mg/ml at 4 1C overnight. After
the incubation of biotinylated secondary Abs, immune complexes
were visualized using Catalyzed Signal Amplification System (Dako,
Kyoto, Japan) according to the manufacturer’s instructions.
Immunofluorescence analyses
RPTECs were cultured on chamber slides (Nalgene Nunc Interna-
tional, Naperville, IL) and were fixed with 3% formaldehyde in PBS
and permeabilized with 100% methanol. After rehydration in
PBS–0.1% Tween 20, the slides were incubated with PBS containing
1% normal donkey serum and 1% bovine serum albumin to reduce
nonspecific reactions. Thereafter, the slides were incubated overnight
at 4 1C with rabbit anti-LC3b or rabbit anti-cleaved caspase-3 pAbs.
After the incubation with fluorochrome-conjugated secondary Abs at
room temperature for 1 h, the slides were stained with 4,6-diamidino-
2-phenylindole and observed using an LSM5Pascal Exciter (Carl Zeiss
Japan, Tokyo, Japan) laser scanning confocal microscope.
In situ TUNEL staining
The paraffin-embedded tissue sections were rehydrated and
permeabilized using Proteinase K (20 mg/ml in PBS) for 15 min at
room temperature. Endogenous peroxidase was inactivated with 3%
hydrogen peroxide in PBS. The sections were subjected to TUNEL
staining with the ApopTag Peroxidase In situ Apoptosis Detection
Kit (CHEMICON International, Temecula, CA), according to the
manufacturer’s instructions. The sections were counterstained with
methyl green solution. To semiquantitatively evaluate caspase
activity and apoptotic cells, five microscopic fields were randomly
selected at  200 magnification. The numbers of TUNEL-positive
cells were enumerated and summed. All measurements were
recorded without a prior knowledge of the experimental procedures.
In another series, RPTECs cultured on the chamber slides were fixed
with 3% formaldehyde in PBS and subjected to TUNEL staining
with the In Situ Apoptosis Detection Kit (Takara Bio, Otsu, Japan),
according to the manufacturer’s instructions. The TUNEL-positive
signals were detected as fluorescence using a LSM5Pascal Exciter
laser scanning confocal microscope.
Electron microscopy
Renal tissues were fixed with 2.5% glutaraldehyde in 100 mmol/l
PBS (pH 7.4) at room temperature. After being washed in
100 mmol/l PBS, the samples were postfixed in 1% osmium
tetroxide, processed by standard procedures, and examined
with a JEM-1220 transmission electron microscope (JEOL, Tokyo,
Japan).
Lysosomal pH assessment
The vacuolar pH in RPTECs was assessed using LysoSensor Yellow/
Blue DND160 (Molecular Probes, Eugene, OR), an acidotropic
agent that emits yellow/blue light depending on the acidity of the
particular organelle. After the cells received LysoSensor at a final
concentration of 2 mmol/l for 2 min at 37 1C, they were washed with
PBS and viewed by fluorescence microscopy using an XF129-2 filter
set (Optoscience, Tokyo, Japan).
Western blotting analysis of RPTECs
RPTECs were cultured with or without cisplatin (50 mmol/l) and
were washed with cold PBS. Thereafter, the cells were incubated with
cold 10% trichloroacetic acid solution for 15 min on ice. The cells
were scraped and centrifuged at 1500 g for 5 min. The cell pellets
were dissolved with sodium dodecyl sulfate sample buffer. Equal
amounts of protein were separated on 10 or 15% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to an
Immobilon-P transfer membrane (Millipore, Billerica, MA). The
membranes were treated with primary Abs overnight at 4 1C and
incubated for 1 h with a horseradish peroxidase–conjugated anti-
goat or anti-rabbit secondary Ab (1:2000 dilution; Dako Japan) at
room temperature for 1 h. Bound Ab complexes were detected using
an enhanced chemiluminescence reagent (Millipore) according to
the manufacturer’s instructions.
Western blotting analysis of mouse kidney proteins
At the indicated time intervals after cisplatin treatment,
kidney tissues were homogenized with a lysis buffer (10 mmol/l
PBS, pH 7.4 containing 0.01% Triton X-100, 0.5% sodium
deoxycholate and 0.1% sodium dodecyl sulfate) containing
Complete Protease Inhibitor Mixture, and Phosphatase Inhibitor
Cocktails for serine/threonine protein phosphatases and tyrosine
protein phosphatases (P2850 and P5726; Sigma-Aldrich) and
centrifuged to obtain lysates. The lysates were analyzed as described
above.
Table 1 | Sequences of the primers used for RT–PCR
Transcript Sequence
Annealing
temperature
(1C) Cycle
Product
size (bp)
IFN-g (F) 50-AGCGGCTGACTGAA
CTCAGATTGTAG-30
60 30 247
(R) 50-GTCACAGTTTTCAGCT
GTATAGGG-30
b-Actin (F) 50-TTCTACAATGAGCTGC
GTGTGGC-30
62 26 456
(R) 50-CTCATAGCTCTTCTCCA
GGGAGGA-30
Abbreviations: F, forward primer; IFN, interferon; R, reverse primer; RT, reverse
transcriptase.
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Statistical analysis
The means and s.e.m. were calculated for all parameters determined
in this study. Statistical significance was evaluated using analysis of
variance or the Mann–Whitney U-test. Po0.05 was accepted as
statistically significant.
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